Strides acquires Sandoz

Strides agreed to acquire Sandoz. Reported deal value: $12M. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.

This page summarizes publicly available information about the transaction as of 2026-03-17. Figures and status may change as filings and press coverage update.

× https://www. thehindubusinessline.com /news/ strides - pharma -arm- spiag - inks - 12 -million- deal -to- acquire - sandoz - generics - portfolio -in- africa /article70754668.ece Copy The deal is expected to close by the end of Q2 FY27 , subject to customary conditions| Photo Credit:dolgachov Strides Pharma International AG , a step-down subsidiary of Strides Pharma Science Limited , has signed an agreement for the acquisition and in-licensing of a portfolio of branded generic products across Sub-Saharan Africa from Sandoz AG , Switzerland , and its group entities